Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2180554
Max Phase: Preclinical
Molecular Formula: C23H32N2O4S
Molecular Weight: 432.59
Molecule Type: Small molecule
Associated Items:
ID: ALA2180554
Max Phase: Preclinical
Molecular Formula: C23H32N2O4S
Molecular Weight: 432.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)CCOC(=O)c1ccc(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)cc1
Standard InChI: InChI=1S/C23H32N2O4S/c1-6-25(7-2)16-17-29-22(26)18-8-12-20(13-9-18)24-30(27,28)21-14-10-19(11-15-21)23(3,4)5/h8-15,24H,6-7,16-17H2,1-5H3
Standard InChI Key: DWKTZRKHBONBEA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 432.59 | Molecular Weight (Monoisotopic): 432.2083 | AlogP: 4.28 | #Rotatable Bonds: 9 |
Polar Surface Area: 75.71 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.65 | CX Basic pKa: 8.98 | CX LogP: 3.57 | CX LogD: 3.27 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.60 | Np Likeness Score: -1.47 |
1. Carosati E, Tochowicz A, Marverti G, Guaitoli G, Benedetti P, Ferrari S, Stroud RM, Finer-Moore J, Luciani R, Farina D, Cruciani G, Costi MP.. (2012) Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase., 55 (22): [PMID:23075414] [10.1021/jm300850v] |
Source(1):